Polymyalgia Rheumatica
📧 Sign up to get email alerts when something new happens for Polymyalgia Rheumatica.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR) [Phase 2]
A Phase 2 trial assessing prednisolone with SPI-62 versus placebo in polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AYLo - AutoimmunitY and Loss of y
Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
A University of Bonn clinical trial is currently recruiting to assess a biomarker in patients with giant cell arteritis and polymyalgia rheu…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
This study investigates predictive factors for treatment response in patients with newly diagnosed polymyalgia rheumatica and giant cell art…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Validation of the PMR Activity Score and Evolution of Patient-reported Outcomes in Patients With Polymyalgia Rheumatica
This study reports the validation of the Polymyalgia Rheumatica Activity Score and the evolution of patient-reported outcomes in PMR patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
The study aims to characterize clinical and immunogenetic features of Giant Cell Arteritis and Polymyalgia Rheumatica. It is currently recru…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
This clinical trial update describes a study aiming to predict diverse glucocorticoid toxicity outcomes across inflammatory rheumatic diseas…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 [Phase 2]
A Phase 2 study evaluating subcutaneous ABBV-154 for Polymyalgia Rheumatica was terminated, with results posted.
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica
A clinical trial update on using 18-FDG PET-CT score-based diagnostics to identify polymyalgia rheumatica; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica [Phase 2]
Phase 2 trial update for bari-citinib in polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica [Phase 2]
Phase 2 trial evaluating tofacitinib as a glucocorticoid-sparing agent in polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of sarilumab in polymyalgia rheumatica has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS [Phase 3]
A Phase 3 clinical trial update for abatacept in early-onset polymyalgia rheumatica (ALORS) is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE) [Phase 3]
Phase 3 trial evaluating tocilizumab for remission-induction and glucocorticoid-sparing therapy in new-onset polymyalgia rheumatica has comp…
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE [Phase 3]
Phase 3 trial assessing safety and efficacy of tocilizumab versus placebo in glucocorticoid-dependent polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica [Phase 2]
Phase 2 clinical trial update on low-dose interleukin-2 for polymyalgia rheumatica.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Treatment With Leflunomide in Patients With Polymyalgia Rheumatica [Phase 3]
Phase 3 clinical trial evaluating leflunomide for polymyalgia rheumatica is in an update, status not specified.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR [Phase 3]
Phase 3 trial comparing Lodotra to prednisone IR in polymyalgia rheumatica was terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Timed Release Tablet Prednisone in Polymyalgia Rheumatica [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated timed release prednisone for polymyalgia rheumatica; status completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Study of Tocilizumab to Treat Polymyalgia Rheumatica [Phase 2]
Phase 2 clinical trial evaluating tocilizumab for treatment of polymyalgia rheumatica has completed with results posted in 2018.
-
CLINICAL_TRIALS withdrawal · 2017-11-20Clinical Trial Update: Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of sirukumab in polymyalgia rheumatica was withdrawn by the sponsor.
-
CLINICAL_TRIALS research · 2017-08-23Clinical Trial Update: Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
A completed research protocol study focused on quantifying pain to aid in the diagnosis of polymyalgia rheumatica.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Delayed Release Prednisone in PMR [Phase 2]
A Phase 2 study evaluating delayed-release prednisone for polymyalgia rheumatica has been terminated.